Bullish: Siris exercises option for Equiniti non-core units; UK, US, and Germany clear merger
BLSH is trading near its 52-week low of $21.76 (13% above the low).
Summary
Siris exercised its option to buy three non-core Equiniti units, and Bullish received competition clearances from the UK, US, and Germany for its $4.2 billion acquisition of Equiniti, keeping the deal on track for a January 2027 close.
Key Events · M&A and Partnerships · BLSH
-
Siris Exercises Option for Non-Core Units
Siris will acquire EQ Retirement Solutions, EQ Customer Resolutions, and Lenvi, carving them out of the Equiniti acquisition. This was a previously disclosed option, now exercised, removing uncertainty.
-
Competition Clearances Received
The UK, US, and Germany have cleared the merger, satisfying a key regulatory condition. Remaining approvals are still required, but antitrust risk is substantially reduced.
-
Deal on Track for January 2027 Close
The $4.2 billion acquisition of Equiniti remains subject to remaining regulatory approvals and customary conditions, with closing expected in January 2027.
-
Strategic Focus Sharpened
By shedding non-core businesses, Bullish retains Equiniti's transfer agent infrastructure and issuer relationships, aligning with its tokenized securities strategy.
Analysis · BLSH · Crypto Assets
Siris has exercised its option to acquire three non-core Equiniti business lines, a carve-out that was previously disclosed but not certain. This removes uncertainty around the deal structure and confirms the $4.2 billion acquisition remains on track for January 2027. Competition clearances from the UK, US, and Germany are a major regulatory milestone, reducing antitrust risk. The update reinforces the strategic logic: Bullish keeps the transfer agent and issuer relationships while shedding non-core operations, sharpening the focus on tokenized securities infrastructure.
At the time of this filing, BLSH was trading at $24.50 on NYSE in the Crypto Assets sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $21.76 to $118.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.